Christopher Worrall
Vice President US Business Development
Nanoform
Chairperson Room 1
Dr. Christopher Worrall obtained his PhD in synthetic organic chemistry from the University of Manchester. After his studies he spent two years developing synthetic processes for GMP syntheses within SAFC before moving to Pharmorphix. Subsequently, Chris has spent 13 years specializing in the area of crystallization and physicochemical modification, starting as a scientist before being promoted to project leader and rising to become US business development manager, and has been involved in the development of 5 commercial products. A native of North West England, Chris has spent the last 9 years in BD in San Diego – where the weather is significantly better – and in May this year became the Vice President of US Business Development for Nanoform.